Top in allergy/asthma: Alpha-gal in health products; asthma treatment adherence
Click Here to Manage Email Alerts
Recent data show that alpha-gal in health products triggers anaphylactic reactions in about half of patients with alpha-gal syndrome, highlighting the potential life-threatening nature of the syndrome without transparent ingredient labeling.
“The next step in this research is addressing these patients’ needs,” Jasmine Uchi, PharmD, director of medical affairs and operations at VeganMed Inc., said. “It is time to put into practice the AMA policy ... on transparency around animal-derived ingredients in labels.”
It was the top story in allergy/asthma last week.
Another top story was a study that found patients overestimated asthma treatment adherence by 47% and physicians by 45% compared with levels of adherence recorded through a mobile application.
Read these and more top stories in allergy/asthma below:
Alpha-gal in health products triggers anaphylaxis in half of alpha-gal syndrome patients
Nearly half of patients with alpha-gal syndrome have had an anaphylactic reaction to health products that include alpha gal, according to a study presented at the DIA 2023 Annual Global Meeting in Boston. Read more.
Patients, physicians overestimate asthma treatment adherence compared with mobile app
Adherence with asthma medication was lower when recorded by a mobile app compared with patient-reported and physician-reported results, according to a study published in Clinical and Translational Allergy. Read more.
24-hour helpline supports patients with food allergy on oral immunotherapy
Patients on oral immunotherapy for food allergy were satisfied with a 24/7 telephone helpline that provided support for their treatment, according to a letter published in Clinical and Translational Allergy. Read more.
ADINA Act would require allergen labeling on OTC, prescription medication
The Allergen Disclosure in Non-Food Articles Act would amend the Food, Drug, and Cosmetic Act to require labels on drugs intended for human use to indicate if they include ingredients derived from the top nine food allergens or glutens. Read more.
Survival rates improve among infants with severe combined immunodeficiency screenings
Five-year survival rates among children with severe combined immunodeficiency remained stable at 72% to 73% from 1982 to 2009 before improving to 87% from 2010 to 2018, according to a study published in The Lancet. Read more.